- Home
- CHYM vs RVTY Comparison
CHYM vs RVTY Comparison
Compare CHYM & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CHYM | RVTY |
|---|---|---|
| Founded | 2012 | 1937 |
| Country | United States | United States |
| Employees | 1519 | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 9.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | CHYM | RVTY |
|---|---|---|
| Price | $19.23 | $98.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 16 |
| Target Price | $31.94 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 3.8M | 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $23.65 | $6.37 |
| Revenue Next Year | $19.12 | $5.10 |
| P/E Ratio | ★ N/A | $48.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.17 | $81.22 |
| 52 Week High | $38.67 | $118.30 |
Technical Indicators
Market Signals| Indicator | CHYM | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 38.53 | 63.26 |
| Support Level | $16.93 | $94.57 |
| Resistance Level | $19.20 | $101.88 |
| Average True Range (ATR) | 1.10 | 3.89 |
| MACD | -0.33 | 1.14 |
| Stochastic Oscillator | 4.46 | 86.58 |
Price Performance
Historical ComparisonAbout CHYM Chime Financial Inc.
Chime Financial Inc is a financial technology company that provides digital banking services through its proprietary technology platform in partnership with third-party banks. The company offers various financial products and services designed to meet members' financial needs, including spending accounts, liquidity solutions, credit-building tools, savings products, and community-focused financial services.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.